Ocera Therapeutics Inc (NASDAQ:OCRX)

4.50
Delayed Data
As of Mar 27
 -0.22 / -4.66%
Today’s Change
4.18
Today|||52-Week Range
12.35
-29.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues10.2M8.4M85.0K341.0K
 
 
 
 
 
Depreciation And Amortization308.0K332.0K324.0K--
 
 
 
 
 
Operating ExpensesGross Income-----239.0K--
 
 
General Expenses30.6M27.2M12.0M24.9M
 
 
 
 
 
Other Operating Expenses0.000.000.00164.0K
 
 
Research And Development24.9M21.0M3.5M14.9M
 
 
 
 
 
Total Operating Expenses30.9M27.5M12.3M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.7M-19.1M-12.3M-24.7M
 
 
 
 
 
Extraordinary Credit0.000.0015.0K--
 
 
Extraordinary Charge0.00-1.4M-3.1M--
 
 
 
Interest Expense On Debt1.6M2.4M193.0K--
 
 
 
 
Other Expenses126.0K27.0K0.00--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.2M-22.8M-15.5M-24.6M
 
 
 
 
 
Discontinued Operations0.000.00-1.9M1.2M
 
 
 
Extraordinary Items0.000.00-86.0K--
 
 
Net Income-22.2M-22.8M-17.4M-23.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.1M6.1M17.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.1M6.1M17.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.64-$10.80-$2.85-$1.34
 
 
 
 
 
EPS Diluted-$14.64-$10.80-$2.84-$1.34
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account